Pub. L. 116-59, div. B, tit. VI, sec. 1603 (as amended)

EXCLUDING AUTHORIZED GENERIC DRUGS FROM CALCULATION OF AVERAGE MANUFACTURER PRICE FOR PURPOSES OF THE MEDICAID DRUG REBATE PROGRAM; EXCLUDING MANUFACTURERS FROM DEFINITION OF WHOLESALER.

Year: 2019Length: 138 wordsOfficial source
SEC. 1603. EXCLUDING AUTHORIZED GENERIC DRUGS FROM CALCULATION OF AVERAGE MANUFACTURER PRICE FOR PURPOSES OF THE MEDICAID DRUG REBATE PROGRAM; EXCLUDING MANUFACTURERS FROM DEFINITION OF WHOLESALER. (a) In General.—Subparagraph (C) of section 1927(k)(1) of the Social Security Act (42 U.S.C. 1396r-8(k)(1)) is amended— (1) in the subparagraph heading, by striking “INCLUSION” and inserting “EXCLUSION”; (2) by striking “a new drug application” and inserting “the manufacturer’s new drug application”; and (3) by striking “inclusive” and inserting “exclusive”. (b) Excluding Manufacturers From Definition of Wholesaler.—Section 1927(k)(11) of the Social Security Act (42 U.S.C. 1396r-8(k)(11)) is amended— (1) by striking “manufacturers,”; and (2) by striking “manufacturer’s and”. (c) [42 U.S.C. 1396r-8 note] Effective Date.—The amendments made by this section shall take effect on the first day of the first fiscal quarter that begins after the date of enactment of this Act.
Cross-references to the US Code
42 U.S.C. 1396r-8 note
Pub. L. 116-59, div. B, tit. VI, sec. 1603 (as amended): EXCLUDING AUTHORIZED GENERIC DRUGS FROM CALCULATION OF AVERAGE MANUFACTURER PRICE FOR PURPOSES OF THE MEDICAID DRUG REBATE PROGRAM; EXCLUDING MANUFACTURERS FROM DEFINITION OF WHOLESALER. | Justis AI